InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,615.35
(
0.55%
)
US TECH 100
19,804.00
(
0.64%
)
Dow Jones
40,000.90
(
0.62%
)
Brent Oil
84.57
(
0.00%
)
Bitcoin
58,003.05
(
0.19%
)
Post# of 252588
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

iwfal

Send PM Follow Ignore
Followers 75
Posts 4700
Boards Moderated 0
Alias Born 09/06/2003

iwfal

Member Level

Re: drbio45 post# 47702

Wednesday, 05/30/2007 11:43:15 PM

Wednesday, May 30, 2007 11:43:15 PM

Post# of 252588
the fda will not approve a drug that has met its primary endpoint in only one phase 3 trial for the indication of Fibromyalgia. end of story.

Argument by assertion. Nice.

I believe what they want to do is have the drug rejected and when cypress gets clobbered they will buy it at a discount.

The next ph iii would probably come in before the FDA rules on the NDA. Logic doesn't fully hold.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up